XTX Topco Ltd cut its stake in Maximus, Inc. (NYSE:MMS - Free Report) by 40.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 7,086 shares of the health services provider's stock after selling 4,793 shares during the period. XTX Topco Ltd's holdings in Maximus were worth $529,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also made changes to their positions in the company. UMB Bank n.a. boosted its position in shares of Maximus by 79.8% in the 4th quarter. UMB Bank n.a. now owns 356 shares of the health services provider's stock valued at $27,000 after purchasing an additional 158 shares during the period. Eastern Bank acquired a new stake in shares of Maximus in the fourth quarter valued at approximately $29,000. V Square Quantitative Management LLC grew its position in shares of Maximus by 65.9% during the fourth quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider's stock worth $34,000 after acquiring an additional 180 shares during the last quarter. R Squared Ltd acquired a new position in shares of Maximus in the 4th quarter valued at $54,000. Finally, IFP Advisors Inc increased its holdings in shares of Maximus by 62.4% in the 4th quarter. IFP Advisors Inc now owns 786 shares of the health services provider's stock valued at $59,000 after acquiring an additional 302 shares during the period. Institutional investors and hedge funds own 97.21% of the company's stock.
Analysts Set New Price Targets
A number of analysts recently weighed in on the stock. Raymond James upgraded shares of Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 price target for the company in a research note on Thursday, January 2nd. StockNews.com lowered Maximus from a "buy" rating to a "hold" rating in a report on Friday, February 14th.
Get Our Latest Stock Report on MMS
Insiders Place Their Bets
In related news, insider Ilene R. Baylinson sold 14,500 shares of the company's stock in a transaction on Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total transaction of $988,030.00. Following the transaction, the insider now owns 2,512 shares of the company's stock, valued at $171,167.68. This represents a 85.23 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Jan Madsen sold 2,439 shares of the firm's stock in a transaction on Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total value of $165,144.69. Following the completion of the sale, the director now directly owns 18,097 shares of the company's stock, valued at approximately $1,225,347.87. This trade represents a 11.88 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by insiders.
Maximus Stock Performance
Shares of NYSE:MMS traded up $0.16 during trading on Wednesday, reaching $68.33. The company had a trading volume of 400,804 shares, compared to its average volume of 550,211. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.72 and a quick ratio of 1.72. The stock's fifty day moving average price is $67.62 and its 200 day moving average price is $74.96. Maximus, Inc. has a fifty-two week low of $63.77 and a fifty-two week high of $93.97. The firm has a market capitalization of $3.87 billion, a price-to-earnings ratio of 14.69 and a beta of 0.68.
Maximus (NYSE:MMS - Get Free Report) last announced its quarterly earnings data on Thursday, February 6th. The health services provider reported $1.61 EPS for the quarter, topping analysts' consensus estimates of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. As a group, equities research analysts predict that Maximus, Inc. will post 6.15 EPS for the current year.
Maximus Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Saturday, May 31st. Shareholders of record on Thursday, May 15th will be issued a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 1.76%. The ex-dividend date is Thursday, May 15th. Maximus's dividend payout ratio is presently 25.81%.
Maximus Company Profile
(
Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Further Reading

Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.